Collegeville, PA, United States of America

Mark James Schulz

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Glaxosmithkline Intellectual Property (No.2) Limited, Glaxosmithkline Intellectual Property Development Limited, Glaxosmithkline LLC. Active years: 2013-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark James Schulz. Retrieved from https://idiyas.com/inventor/mark-james-schulz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 25.0

 

Average Co-Inventor Count = 10.4

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2013-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Mark James Schulz: Innovator in Pharmaceutical Compounds

Introduction

Mark James Schulz is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work primarily focuses on developing novel compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents, Schulz has developed modulators of the stimulator of interferon genes (STING). These compounds are characterized by a specific formula that includes various defined components. Another significant invention is the Enhancer of Zeste Homolog 2 inhibitors, which relates to novel compounds that inhibit EZH2 and includes pharmaceutical compositions containing these compounds.

Career Highlights

Throughout his career, Schulz has worked with prominent companies, including GlaxoSmithKline Intellectual Property Limited and GlaxoSmithKline Intellectual Property Development Limited. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Schulz has collaborated with notable colleagues, including Juan I Luengo and Stuart Paul Romeril. These partnerships have likely enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Mark James Schulz is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact medical treatments significantly. His contributions to the field are marked by his innovative patents and collaborations with industry professionals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…